Down-Regulation of Angiogenic Inhibitors: A Potential Pathogenic Mechanism for Diabetic Complications
Journal:
Current Diabetes Reviews
Volume:
1
Page:
183-196
Author(s):
Jian-xing Ma, Sarah X. Zhang and Joshua J. Wang
Angiotensin II-Induced Signaling Pathways in Diabetes
Journal:
Current Diabetes Reviews
Volume:
1
Page:
197-202
Author(s):
Mario B. Marrero, David Fulton, David Stepp and David M. Stern
Gestational Diabetes Mellitus: A Review from 2004
Journal:
Current Diabetes Reviews
Volume:
1
Page:
203-213
Author(s):
Richard X. Davey
Basal Bolus Dosing: A Clinical Experience
Journal:
Current Diabetes Reviews
Volume:
1
Page:
215-220
Author(s):
Allen B. King and Dana U. Armstrong
Galectin-1 is a Novel Factor that Regulates Myotube Growth in Regenerating Skeletal Muscles
Journal:
Current Drug Targets
Volume:
6
Page:
395-405
Author(s):
Katsuya Kami and Emiko Senba
Galectin-1 as a Potential Therapeutic Agent for Amyotrophic Lateral Sclerosis
Journal:
Current Drug Targets
Volume:
6
Page:
407-418
Author(s):
T. Kato, C.- H. Ren, M. Wada and T. Kawanami
Editorial [Hot Topic: Potential New Therapeutic Strategies of Diabetic Vascular Complications (Guest Editor: Toyoshi Inoguchi)]
Journal:
Current Drug Targets
Volume:
6
Page:
445-446
Author(s):
Toyoshi Inoguchi
Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System
Journal:
Current Drug Targets
Volume:
6
Page:
447-452
Author(s):
Khin Mar Myint, Yasuhiko Yamamoto, Shigeru Sakurai, Ai Harashima, Takuo Watanabe, Hui Li, Akihiko Takeuchi, Kazunobu Yoshimura, Hideto Yonekura and Hiroshi Yamamoto
The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Journal:
Current Drug Targets
Volume:
6
Page:
453-474
Author(s):
M. C. Thomas, J. W. Baynes, S. R. Thorpe and M. E. Cooper
NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive β-Cell Dysfunction and Metabolic Syndrome
Journal:
Current Drug Targets
Volume:
6
Page:
495-501
Author(s):
Toyoshi Inoguchi and Hajime Nawata